SPPI SHAREHOLDER ALERT: Jakubowitz Law Reminds Spectrum Shareholders of a Lead Plaintiff Deadline of February 3, 2023
NEW YORK, Dec. 30, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…
1,030$
Echtzeit-Aktienkurs Spectrum Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Spectrum Pharmaceuticals Inc. Aktie
SPECTRUM DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Spectrum To Contact Him Directly To Discuss Their Options
NEW YORK, Dec. 29, 2022 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential…
ROSEN, A LEADING NATIONAL FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
New York, New York--(Newsfile Corp. - December 29, 2022) - WHY: Rosen Law Firm, a global investor rights law firm,…
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 29, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SPPI LAWSUIT ALERT: Levi & Korsinsky Notifies Spectrum Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 29, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Spectrum Pharmaceuticals, Inc. ("Spectrum" or the…
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 28, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 3, 2023 - (NASDAQ: SPPI)
NEW YORK, Dec. 28, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Spectrum Pharmaceuticals,…
ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
NEW YORK, Dec. 27, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 27, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Acton Lawsuit and Upcoming Deadline - SPPI
NEW YORK, Dec. 26, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum…
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
New York, New York--(Newsfile Corp. - December 25, 2022) - WHY: Rosen Law Firm, a global investor rights law firm,…
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 23, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 3, 2023 in Spectrum Lawsuit - SPPI
New York, New York--(Newsfile Corp. - December 23, 2022) - Levi & Korsinsky, LLP notifies investors in Spectrum Pharmaceuticals,…
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 22, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SPPI LAWSUIT ALERT: Levi & Korsinsky Notifies Spectrum Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 22, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Spectrum Pharmaceuticals, Inc. ("Spectrum" or the…
Spectrum Class Action: Levi & Korsinsky Reminds Spectrum Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 3, 2023 - SPPI
New York, New York--(Newsfile Corp. - December 21, 2022) - Levi & Korsinsky, LLP notifies investors in Spectrum Pharmaceuticals, Inc.…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 3, 2023 - (NASDAQ: SPPI)
NEW YORK, Dec. 21, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Spectrum Pharmaceuticals,…
ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
NEW YORK, Dec. 20, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 20, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 3, 2023 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Shareholders
NEW YORK, Dec. 20, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
New York, New York--(Newsfile Corp. - December 19, 2022) - WHY: Rosen Law Firm, a global investor rights law firm,…
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 19, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI
New York, New York--(Newsfile Corp. - December 17, 2022) - Pomerantz LLP is investigating claims on behalf of investors of…
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
New York, New York--(Newsfile Corp. - December 16, 2022) - WHY: Rosen Law Firm, a global investor rights law firm,…
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 16, 2022) - The Schall Law Firm, a national shareholder rights litigation firm,…
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 15, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SPPI LAWSUIT ALERT: Levi & Korsinsky Notifies Spectrum Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Dec. 15, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Spectrum Pharmaceuticals, Inc. ("Spectrum" or the…
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 14, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 3, 2023 - (NASDAQ: SPPI)
NEW YORK, Dec. 14, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Spectrum Pharmaceuticals,…
SPPI INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPPI
NEW YORK, Dec. 13, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing…
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 13, 2022) - The Schall Law Firm, a national shareholder rights litigation firm,…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI
NEW YORK, Dec. 13, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc.…
Bronstein, Gewirtz & Grossman, LLC Notifies Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively Participate
NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class…
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 12, 2022) - The Schall Law Firm, a national shareholder rights litigation firm,…
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Spectrum Investors of a Lead Plaintiff Deadline of February 3, 2023
NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Attention Spectrum Pharmaceuticals, Inc. ("Spectrum") (NASDAQ: SPPI) shareholders: The Law Offices of Vincent…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI
New York, New York--(Newsfile Corp. - December 10, 2022) - Pomerantz LLP is investigating claims on behalf of investors of…
National Law Firm Investigating Spectrum Pharmaceuticals, Inc. Over Alleged False/Misleading Statements Regarding New Drug Application
Complaint Alleges Spectrum Pharmaceuticals Failed to Disclose Negative Data from Clinical Trials ONTARIO, Calif., Dec. 9, 2022 /PRNewswire/ -- McCune…
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 8, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - December 7, 2022) - The Schall Law Firm, a national shareholder rights litigation firm,…
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI
NEW YORK, Dec. 5, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc.…
Insiderhandel: Aufsichtsrat kauft Aktien von Spectrum Pharmaceuticals im Wert von 22.500$
Vacirca, Jeff L. - Aufsichtsrat - Tag der Transaktion: 2022-11-30...…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI
New York, New York--(Newsfile Corp. - November 30, 2022) - Pomerantz LLP is investigating claims on behalf of investors of…
Spectrum Pharma sheds 14% after FDA snub for lung cancer therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Spectrum Pharmaceuticals Says Cancer Drug Failed to Win FDA Approval
Spectrum Pharmaceuticals Says Cancer Drug Failed to Win FDA Approval...…
Spectrum Pharmaceuticals downgraded to neutral from buy at B. Riley
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - SPPI
NEW YORK, Oct. 31, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate…
Form 8-K SPECTRUM PHARMACEUTICALS For: Oct 19
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI
NEW YORK, Oct. 10, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc.…